Obesity Clinical Trial
— VALOR-UPOfficial title:
Enhanced Protein Intake During Obesity Reduction in Older Male Veterans: Differences in Physical Function and Muscle Quality Responses by Race
Verified date | April 2024 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Diabetes is a major health concern in obese older Veterans, especially in those who are African American. The negative impact of diabetes on muscle and physical function contributes to metabolic as well as physical decline and is under-studied. This randomized controlled trial compares a higher-protein, weight loss regimen previously shown to improve physical function to an Recommended Dietary Allowance (RDA) protein intervention in obese older male Veterans with pre-diabetes and functional limitations. Equal numbers of white and black male Veterans will be studied, filling gaps in the investigators' knowledge of differential responses by race as well as obesity interventions for men in general. The primary outcome is functional performance by Short Physical Performance Battery and secondary measures include muscle quality, insulin sensitivity, lean body mass, physical activity, recent falls and fear of falling, instrumental activities of daily living, and quality of life measured at 0, 3 and 6 months. The goal of this research is to accelerate functional recovery and enhance independence in obese male Veterans, which is strongly aligned with the RR&D mission to "maximize the physical and social autonomy of Veterans".
Status | Completed |
Enrollment | 105 |
Est. completion date | March 29, 2024 |
Est. primary completion date | March 26, 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 55 Years and older |
Eligibility | Inclusion Criteria: - Male Veterans - African American or Caucasian - Obese (BMI > 30 kg/m2) - Age 55+ years - Pre-diabetes (confirmed fasting plasma glucose 100 and <126 mg/dL) or HbA1c 5.7-6.4% - Short Physical Performance Battery score of 4 to 10 units - Age-normal renal function - English speaking - Able to record dietary intake or has a proxy who can record dietary intake - Willing and able to be randomized to either intervention group Exclusion Criteria: - Presence of unstable or symptomatic life-threatening illness - Glomerular filtration rates (GFR) less than 45 mL/min - A GFR of 45-59 requires bi-monthly testing per the investigators' established algorithm - Those with a GFR <45 mL/min are excluded - Mini Cog score of <3 --Vegetarian - Neurological conditions causing functional impairments, including: - Parkinson's Disease - multiple sclerosis - permanent disability due to stroke - Inability to complete physical function assessment - History of significant weight instability - Contraindicated medications, including narcotic mail-outs and active substance abuse - Any psychiatric condition that would prevent the subject from participating in a group intervention setting, including diagnosed personality disorders - Primary care provider disapproves participation |
Country | Name | City | State |
---|---|---|---|
United States | Durham VA Medical Center, Durham, NC | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Short Physical Performance Battery (SPPB) | Three different Balance test-(side-by-side, semi-tandem, tandem). They hold each position for 10 seconds
Possible Score for Balance Test: 0-4 Possible Score for whole SPPB Test 0-12 |
0, 3 and 6 months | |
Primary | Change in Short Physical Performance Battery (SPPB) | Gait speed (4-meter timed walk)- we are measuring there normal walk speed.
Possible Score for Gait Speed: 0-4 Possible Score for whole SPPB Test 0-12 |
0, 3, 6 months | |
Primary | Change in Short Physical Performance Battery (SPPB) | Lower Body Strength-5 Chair Stand as fast as they can do.
Chair Stand- With arms across chest, stand up completely, returns to seated Possible Score for Chair Stands: 0-4 Possible Score for whole SPPB Test 0-12 |
0, 3, 6 months | |
Secondary | Change in Body Weight | Same scale, light clothing and no shoes, measured to nearest 0.1 kg | 0, 3 and 6 months | |
Secondary | Change in 6 Minutes Walk Test (aerobic endurance) | As many walking laps as possible in six minutes between cones placed 40 meters apart | 0, 3 and 6 months | |
Secondary | Change in 8-ft Up and Go (agility/dynamic balance) | Begins seated. On word 'go' stands, walks around a cone 8 feet away, returns to seated. | 0,3, and 6 months | |
Secondary | Change in 30 second chair stands (lower body strength) | With arms across chest, stand up completely, returns to seated as many times as possible in 30 seconds. | 0, 3, and 6 months | |
Secondary | Change in Isokinetic knee extension peak torque (muscle strength) | Knee extensor at 60 degrees with a dynamometer (HUMAC NORM Isokinetic Extremity System). Average peak torque for three trials will be recorded. | 0, 3, and 6 months | |
Secondary | Change in Computerized Axial Tomography (CAT) scan | Cross sectional area of the thigh without contrast to determine muscle mass. | 0, 3, and 6 months | |
Secondary | Change in Isometric hand grip (upper body strength) | Jamar Hand Dynamometer (Sammons Preston Rolyan). Highest of three trials/hand. | 0, 3, and 6 months | |
Secondary | Change in Minimal Waist Circumference | At smallest horizontal circumference above umbilicus and below xiphoid process. | 0, 3, and 6 months | |
Secondary | Change in Body Composition: BodPod | Air displacement plethysmography method (Life Measurement, Inc., Concord, CA). The Cardio Pulmonary, Metabolic and Body Composition (COSMED) BodPod has excellent sensitivity and test-to-test reliability, ease of use, and non-invasive nature, which is important for full participation from this population. | 0, 3, and 6 months | |
Secondary | Change in number of falls and fear of falling | In-person interview with questionnaire. This is a open ended questionnaire to see the change in number of times a person falls between time points. Yes or no response to the question, "Do you have a fear of falling?" | 0, 3, 6 months | |
Secondary | Mini-Cog | Screens for cognitive impairment with minimal language content, reduces cultural and educational bias. A 3-item recall component plus a Clock Drawing Test.
The items recall component Score: 3 The Normal Clock Drawing Score: 2 Eligible score to be in study is 3. |
Baseline | |
Secondary | Change in Short Form-36 (SF-36) Health Survey | Quality of Life Questionnaires The SF-36 measures 8 QOL domains which are dichotomized into physical (functioning, role limitations-physical, pain, general health) and mental health (vitality, social functioning, role limitations-emotional, and emotional/mental health). Item scores were converted to a 0-100 point scale; domain scores were derived by averaging individual items within the subscale; and physical composite and mental health composite scores were derived by averaging the four component domains of each. Higher values are indicative of better QOL | 0, 3, 6, 9, 12 months | |
Secondary | Change in Profile of Mood States (POMS) | Mood Questionnaires The 30-item POMS measures mood and mood changes, has low respondent burden, and includes 6 subscales: tension, depression, anger, fatigue, confusion and vigor (all with range 0-20). Total mood disturbance (TMD) is derived from POMS using the following formula, TMD = (Sum of all subscales except vigor) - vigor (range -20 - 100). | 0, 3, 6, 9, 12 months | |
Secondary | Change in Center for Epidemiologic Studies Depression Scale (CES-D) | Depression Questionnaires Individuals were coded as positive for depression if they had a CES-D score of 16 and/or had self-report of depression diagnosis at baseline. In addition to the total score, the CES-D includes 4 subscales: depressed affect (range 0-21), positive affect (range 0-12), somatic (range 0-21), and interpersonal (range 0-6). | 0, 3, 6, 9, 12 months | |
Secondary | Change in Perceived Stress Scale (PSS) | Stress Questionnaires The PSS assesses the degree to which situations in one's life are considered stressful (range 0-40).
Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress. |
0, 3, 6, 9, 12 months | |
Secondary | Change in Pittsburgh Sleep Quality Index (PSQI) | Quality of sleep Questionnaires Reported PSQI values include only these six component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, and use of sleeping medication (all with a range 0-3).
The PSQI includes a scoring key for calculating a patient's seven subscores, each of which can range from 0 to 3. The subscores are tallied, yielding a "global" score that can range from 0 to 21. A global score of 5 or more indicates poor sleep quality; the higher the score, the worse the quality. |
0, 3, 6, 9, 12 months | |
Secondary | Change in Satisfaction with Life Scale (SWLS) | Life Satisfaction Questionnaires The SWLS evaluates global life satisfaction, an important component of subjective well-being (range 5-35).
The SWLS is a 7-point Likert scale style response scale. The possible range of scores is 5-35, with a score of 20 representing a neutral point on the scale. Scores between 5-9 indicate the respondent is extremely dissatisfied with life, whereas scores between 31-35 indicate the respondent is extremely satisfied. |
0, 3, 6, 9, 12 months | |
Secondary | Change in 3-day diet record | 3-day diet record by multiple pass; analyzed Food Processor (Version 10.13, 2013; ESHA Research); | 0, 3, 6, [9, 12] months | |
Secondary | Change in Protein Checklist Form | RedCap analysis for protein they have consumed | 0,1,2,3,4,5,6 months | |
Secondary | Change in Actigraph, Axis accelerometer (activity counts, step counts, physical activity intensity) | Actigraph WGT3X-BT activity counts at 1-s epoch from three orthogonal axes at 30 Hz sampling frequency. | 0, 3, 6 months (7 days each time point) | |
Secondary | Change in Metabolic Panel (LabCorp)- A Blood Draw and testing | Routine chemistries, blood testing | 0, 3, 6 months | |
Secondary | Change in Glucose Tolerance Test (OGTT) (78-80), blood | Ingestion of a 75 g glucose load with blood draws at 0, 10, 20, 30, 60, 90, 120, 150 and 180 minutes. | 0, 3, 6 months | |
Secondary | Change in Daily food journal (Adherence) | Daily food journal assessed by RD every week | we will collect the daily food journal Up to 36 weeks through study completation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |